Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CTSB | P07858 | 2/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL112859 | 0.85 | ALDH1A1 (0.64) | ALDH1A1L3MBTL1MAPK1SLC6A2SLC6A3 | |
| SCHEMBL30853559 | 0.84 | TRPA1 (0.49) | ALDH1A1SLC6A2KMT2ALMNATRPA1 | |
| Ammonia Solution, Strong SCHEMBL27788705 | 0.84 | ALDH1A1 (0.62) | ALDH1A1L3MBTL1MAPK1SLC6A2SLC6A3 | |
| Hydrochloric Acid SCHEMBL29090140 | 0.84 | ALDH1A1 (0.62) | ALDH1A1L3MBTL1MAPK1SLC6A2SLC6A3 | |
| Acetic Acid SCHEMBL27664299 | 0.82 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1MAPK1SLC6A2SLC6A3 | |
| SCHEMBL517462 | 0.82 | SMN1; SMN2 (0.57) | ALDH1A1MAPK1SLC6A2LMNATRPA1 | |
| SCHEMBL27652957 | 0.81 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1MAPK1SLC6A2SLC6A3 | |
| SCHEMBL28727407 | 0.80 | SMN1; SMN2 (0.55) | ALDH1A1MAPK1SLC6A2LMNATRPA1 | |
| SCHEMBL28246706 | 0.80 | HIF1A (0.55) | ALDH1A1MAPK1SLC6A2KMT2ALMNA | |
| Propionic Acid SCHEMBL18954286 | 0.79 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1MAPK1SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | disclosed |
| CN-113054191-B | Binder solution for all-solid battery and electrode slurry including the same | 现代自动车株式会社 | 2025-06-13 | — | — | CN | disclosed |
| CN-119156438-A | Perfume composition for sleep improvement | 国际香料和香精公司 | 2024-12-17 | — | — | CN | disclosed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | disclosed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | disclosed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | disclosed |
| EP-3310893-B2 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2024-02-28 | — | — | EP | disclosed |
| EP-4319715-A1 | FRAGRANCE COMPOSITION | Givaudan SA (CH) | 2024-02-14 | — | — | EP | disclosed |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-02-08 | — | — | US | disclosed |
| EP-4288022-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-12-13 | — | — | EP | disclosed |
| WO-2022214636-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2022-10-13 | — | — | WO | disclosed |
| WO-2022167123-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-08-11 | — | — | WO | disclosed |
| EP-4039244-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | AOX1, TYR, OCIAD1 | ALDH1A1 116/4885L3MBTL1 1658/4885MAPK1 4078/4885 |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | ALDH1A1 413/4885L3MBTL1 2882/4885MAPK1 4197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.